Anticancer Agents from Natural Products -

Anticancer Agents from Natural Products

Buch | Hardcover
600 Seiten
2005
Lewis Publishers,U.S. (Verlag)
978-0-8493-1863-4 (ISBN)
186,95 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
Offers a biochemical and chemical rationale to the search for plant, marine, or microbial sources that may provide templates for drug lead optimization and synthetic drug design. This work provides an analysis of the research and development of some of the effective anticancer agents that are natural products or derived from natural product leads.
Plants, marine organisms, and microorganisms have evolved complex chemical defense and signaling systems that are designed to protect them from predators and provide other biological benefits. These organisms thus produce substances containing novel chemotypes that may have beneficial effects for humans. As collection methods improve and new screening techniques and molecular targets proliferate, natural products are once again taking a central part of modern pharmaceutical research. Anticancer Agents from Natural Products analyzes current clinically-used anticancer agents that are natural products or clearly derived from natural product leads.

This multi-authored volume provides a historical, biochemical, and chemical rationale to the search for plant, marine, or microbial sources that may provide future templates for drug lead optimization and synthetic drug design. Grouped by source organism, each chapter includes the history of the drug and a discussion of its mechanism in action, medicinal chemistry, and biochemistry. The authors characterize each compound by its structure, genetics, molecular biology, synthesis, and possible derivatives. They also discuss /approaches to drug discovery and development, including the use of combinatorial biosynthetic techniques, testing methods, and ways to obtain economically viable amounts of the drug. The final chapter covers drug candidates that are in preclinical or clinical development and may be used in the future.

Edited by leading scientists who have contributed enormously to natural product development and potential anticancer natural products, Anticancer Agents from Natural Products is a convenient summary of the current status of research and development of some of the most effective anticancer agents available today. It is an ideal foundation for scientists engaged in developing new and improved drugs based on natural sources.

Introduction; G.M. Cragg, David G. I. Kingston, and D.J. Newman

Camptothecin and its Analogs; N.J. Rahier, C.J. Thomas, and S.M. Hecht

The Discovery and Development of the Combretastatins; K.G. Pinney, C. Jelinek, K. Edvardsen, D.J. Chaplin, and G.R. Pettit

Homoharringtonine and Related Compounds; H. Itokawa, X. Wang, and K.-H. Lee

Podophyllotoxins and Analogs; K.-H. Lee and Z. Xiao

Taxol and Its Analogs; David G. I. Kingston

The Vinca Alkaloids; F. Guéritte and J. Fahy

The Bryostatins; D.J. Newman

The Isolation, Characterization, and Development of a Novel Class of Potent Antimitotic Macrocyclic Depsipeptides: The Cryptophycins; R.S. Al-Awar and C. Shih

Chemistry and Biology of the Discodermolides, Potent Mitotic Spindle Poisons; S.P. Gunasekera and A.E. Wright

The Dolastatins: Novel Antitumor Agents from Dolabella auricularia; E. Flahive and J. Srirangam

Ecteinascidin 743 (ET-743; Yondelis™), Aplidine, and Kahalalide F; R. Henriquez, G. Faircloth, and C. Cuevas

Discovery of E7389, a Fully Synthetic Macrocyclic Ketone Analog of Halichondrin B; M.J. Yu, Y. Kishi, and B.A. Littlefield

HTI-286, A Synthetic Analog of the Antimitotic Natural Product Hemiasterlin; R.J. Andersen and M. Roberge

The Actinomycins; A.B. Mauger and H. Lackner

Anthracyclines; F.M. Arcamone

Ansamitocins (Maytansinoids); T.-W. Yu and H.G. Floss

Benzoquinone Ansamycins; K.M. Snader

Bleomycin Group of Antitumor Agents; S.M. Hecht

Biochemical and Biological Evaluation of (+)-CC-1065 Analogs and Conjugates with Polyamides; R. Kumar and J.W. Lown

Epothilone, a Myxobacterial Metabolite with Promising Antitumor Activity; G. Höfle and H. Reichenbach

Enediynes; P.R. Hamann, J. Upeslacis, and D.B. Borders

The Mitomycins; W.A. Remers

Staurosporines and Structurally Related Indolocarbazoles as Antitumor Agents; M. Prudhomme

Combinatorial Biosynthesis of Anticancer Natural Products; M.G. Thomas, K.A. Bixby, and B. Shen

Developments and Future Trends in Anticancer Natural Products Drug Discovery; D.J. Newman and G.M. Cragg
Index

Erscheint lt. Verlag 13.6.2005
Zusatzinfo 51 Tables, black and white; 19 Illustrations, color; 340 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 178 x 254 mm
Gewicht 1247 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 0-8493-1863-7 / 0849318637
ISBN-13 978-0-8493-1863-4 / 9780849318634
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00